The Missing Layer: How Proteomics Elevates Your Multiomics Data
Tuesday, May 05 at 12:00 pm
-
1:00 pm
Add to Calendar
2026-05-05 12:00:00
2026-05-05 13:00:00
The Missing Layer: How Proteomics Elevates Your Multiomics Data
We invite you to join our seminar at UCSF Mission Bay campus with Guanghui Han (General Manager Proteomics, Novogene). For lunch, register here.
Multi-omics approaches overcome the limitations of single-omics by capturing biological processes across multiple molecular layers, enabling more accurate and reliable insights. This presentation outlines key multi-omics strategies, technologies, and analytical frameworks, including their applications in target discovery, biomarker identification, and mechanism-of-action studies. We further demonstrate how integrated omics data enhances interpretation through cross-validation and multi-level analysis. A case study in colorectal cancer illustrates the power of multi-omics in identifying disease-specific molecular patterns and potential biomarkers. Overall, multi-omics serves as a powerful platform to advance precision medicine and drug development.
550 16th Street
Mission Hall, 1406
San Francisco, CA 94158
United States
View on Map
Institute For Human Genetics
[email protected]
America/Los_Angeles
public
550 16th Street
Mission Hall, 1406
San Francisco, CA 94158
United States
View on Map
We invite you to join our seminar at UCSF Mission Bay campus with Guanghui Han (General Manager Proteomics, Novogene). For lunch, register here.
Multi-omics approaches overcome the limitations of single-omics by capturing biological processes across multiple molecular layers, enabling more accurate and reliable insights. This presentation outlines key multi-omics strategies, technologies, and analytical frameworks, including their applications in target discovery, biomarker identification, and mechanism-of-action studies. We further demonstrate how integrated omics data enhances interpretation through cross-validation and multi-level analysis. A case study in colorectal cancer illustrates the power of multi-omics in identifying disease-specific molecular patterns and potential biomarkers. Overall, multi-omics serves as a powerful platform to advance precision medicine and drug development.